BioSpace News Archive

Drug Development

LEO Pharma Announces Positive Results From Phase 2b Clinical Study For Tralokinumab In Atopic Dermatitis

March 3, 2017
·
4 min read
FDA

BioCad: The First Ever Biosimilar Of Interferon Beta-1a Approved In Russia

March 3, 2017
·
1 min read
Business

TetraPhase To Host Conference Call On March 8 To Discuss Fourth Quarter And Full Year 2016 Financial Results And Provide Corporate Update

March 3, 2017
·
1 min read
Business

Synthetic Biologics Reports 2016 Year End Operational Highlights And Financial Results

March 3, 2017
·
11 min read
Business

Otonomy Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update

March 3, 2017
·
1 min read
Business

Senomyx, Inc. Announces Fourth Quarter And Full Year 2016 Financial Results

March 3, 2017
·
8 min read
Policy

SCYNEXIS, Inc. Delays Initiation Of New Clinical Studies Using The IV Formulation Of SCY-078 At FDA’s Request

March 3, 2017
·
2 min read
Pharm Country

Immunomedics Board Institutes Measures As Stockholder Fiduciaries To Preserve Their Best Business Judgment To Protect The Rights Of All Stockholders

March 3, 2017
·
11 min read
Drug Development

MorphoSys AG Announces That Its Licensee Janssen R&D Has Reported New Data From Two Phase III Studies Of Guselkumab In Plaque Psoriasis

March 3, 2017
·
3 min read
Policy

Edwards Lifesciences Gets Split Decision In UK Heart Valve Patent Spat With Boston Scientific

March 3, 2017
·
2 min read